한국어
Quantus

Edesa Biotech

EDSA · Nasdaq
$4.73-0.63%
2026-09-04 close

Edesa Biotech last closed at $4.73 (-0.63%) on 2026-09-04. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…
Close
Market Leader RS 91 · top 9%

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

D
Overall: 건강관리 638/745 · top 86%
Factor composite · relative position in sector

PER — · PBR 19.9 — own-history percentile 59/100 · 7/100

Open self-history band
PER59/100
PBR7/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2025
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -2.63
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
-2.63
Beneish M-Score

Statistical flag unavailable

Sloan accrual
1.01%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

4/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score4/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROAPass
  • Accruals (OCF > net income)Not passed

Leverage & liquidity

  • Lower debtPass
  • Higher current ratioPass
  • No new sharesPass

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About Edesa Biotech
What technical signals does Edesa Biotech (EDSA) have?
Edesa Biotech current technical signals: no active technical signal.
Is Edesa Biotech a cup-and-handle pattern?
No. Edesa Biotech has no valid cup-and-handle signal right now.
What are Edesa Biotech's financials and valuation?
Edesa Biotech's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy